PodParley PodParley

#22: Mpox (formerly monkeypox) with Dr. Aaron Oom, Ph.D.

An episode of the Inflammatory Content podcast, hosted by Kellen Cavagnero, Ph.D., titled "#22: Mpox (formerly monkeypox) with Dr. Aaron Oom, Ph.D." was published on October 26, 2024 and runs 71 minutes.

October 26, 2024 ·71m · Inflammatory Content

0:00 / 0:00

In this episode, Kellen is joined by Dr. Aaron Oom, a Postdoctoral Scholar in the lab of Dr. Mark Mulligan at NYU Langone Health. Aaron is an expert in virology and immunology. He completed his Ph.D. in the lab of Dr. John Guatelli’s at UC San Diego. Aaron has made significant contributions to our understanding of viruses including HIV, Zika, and Dengue. Now, as a Postdoctoral Scholar in the Mulligan lab, he’s focused on Mpox (formerly known as monkeypox), which has recently re-emerged as a major global health threat. In this conversation, Kellen and Aaron discuss Aaron’s recent mpox publication, the challenges of transitioning to independence, the tough decisions around “killing” projects that aren’t working, and much more. Relevant Links:• Mulligan Lab Website: https://med.nyu.edu/research/mulligan-lab/• Aaron’s MedRxiv preprint: https://www.medrxiv.org/content/10.1101/2024.01.28.24301893v1• Mpox review: https://www.nature.com/articles/s41577-022-00775-4If you enjoy Inflammatory Content and want to help me keep the conversations going, consider supporting the podcast! You can write a review, share this episode with friends and colleagues, or make a donation to help keep the show ad-free and thriving. Your contributions, big or small, go directly toward covering production costs and allow me to bring you even more Inflammatory Content. You can donate directly here: https://venmo.com/Kellen-Cavagnero.I’d love to hear from you! Feel free to reach out with questions, feedback, or topic suggestions via email at [email protected], on X (formerly Twitter) @KellenCavagnero, or connect with me on LinkedIn.Stay curious and keep exploring at www.inflammatorycontent.com.

In this episode, Kellen is joined by Dr. Aaron Oom, a Postdoctoral Scholar in the lab of Dr. Mark Mulligan at NYU Langone Health. Aaron is an expert in virology and immunology. He completed his Ph.D. in the lab of Dr. John Guatelli’s at UC San Diego. Aaron has made significant contributions to our understanding of viruses including HIV, Zika, and Dengue. Now, as a Postdoctoral Scholar in the Mulligan lab, he’s focused on Mpox (formerly known as monkeypox), which has recently re-emerged as a major global health threat.

In this conversation, Kellen and Aaron discuss Aaron’s recent mpox publication, the challenges of transitioning to independence, the tough decisions around “killing” projects that aren’t working, and much more.

Relevant Links:

• Mulligan Lab Website: https://med.nyu.edu/research/mulligan-lab/

• Aaron’s MedRxiv preprint: https://www.medrxiv.org/content/10.1101/2024.01.28.24301893v1

• Mpox review: https://www.nature.com/articles/s41577-022-00775-4

If you enjoy Inflammatory Content and want to help me keep the conversations going, consider supporting the podcast! You can write a review, share this episode with friends and colleagues, or make a donation to help keep the show ad-free and thriving. Your contributions, big or small, go directly toward covering production costs and allow me to bring you even more Inflammatory Content. You can donate directly here: https://venmo.com/Kellen-Cavagnero.

I’d love to hear from you! Feel free to reach out with questions, feedback, or topic suggestions via email at [email protected], on X (formerly Twitter) @KellenCavagnero, or connect with me on LinkedIn.

Stay curious and keep exploring at www.inflammatorycontent.com.

Praat erover: leven met een chronische ziekte AbbVie Belgium & Luxembourg Leren leven met een chronische ziekte, dat betekent dat je leven fundamenteel verandert. Het betekent een kruis door bepaalde activiteiten. Het is een uitdaging, elke dag. De patiënten die getuigen in deze podcast leven met een reumatische ontstekingsziekte. Ze doen er alles aan om het beste leven te leiden dat mogelijk is, ondanks hun ziekte. Alles, om het doel te bereiken dat ‘remissie’ heet. Alles om een normaal leven te leiden, simpel gezegd. Ze leggen uit hoe hun ziekte hun leven verandert, en hoe ze de dagelijkse beproevingen doorstaan. Ze vertellen over hun diepste wensen en hun hoop voor de toekomst.*Het vierde seizoen van "Praat erover" gaat over migraine.*Het derde seizoen van "Praat erover" gaat over psoriasis. *Het tweede seizoen van "Praat erover" richt zich op inflammatoire darmziekte (IBD), de ziekte van Crohn en colitis ulcerosa.*Het eerste seizoen van "Praat erover" gaat over inflammatoire reumatische aandoeningen.  Voor meer informatie :www.abbvie.be (http://ww Nebraska Food for Health Center The multidisciplinary Nebraska Food for Health Center brings together strengths in agriculture and medicine from throughout the University of Nebraska system. We help develop hybrid crops and foods to improve the quality of life of those affected by critical diseases including heart disease, diabetes, obesity, cancers, inflammatory bowel disease and mental disorders. Exploring Best Practices for Diagnosis & Management of Adult-Onset Still's Disease AOSD Podcast Adult-onset Still’s disease (AOSD) is a rare, polygenic autoinflammatory syndrome with a pathogenesis similar to systemic juvenile inflammatory arthritis. Join Drs. Petros Efthimiou and Olga Petryna as they discuss making the diagnosis of AOSD through interpretation of clinical and laboratory findings and careful exclusion of other diseases. The faculty review the evidence related to the variety of medications often used to treat patients with AOSD, focusing on canakinumab, the only medication approved in the United States for the disease. Talk IBC Terry Arnold Talk IBC is where we discuss things related to inflammatory breast cancer, from patient's personal stories to the latest in research. This podcast is sponsored by The IBC Network Foundation.
URL copied to clipboard!